Identification and validation of γ-Linolenic acid as a natural FABP5 inhibitor in hepatocellular carcinoma through deep learning and experimental approaches
Key Points
Identification of γ-linolenic acid reveals its role as a natural FABP5 inhibitor, important for treating hepatocellular carcinoma.
Deep learning analysis highlights γ-linolenic acid's potential, acting as an innovative compound against liver cancer.
Experimental approaches confirm the inhibitory effect of γ-linolenic acid on FABP5, supporting its therapeutic use.
The findings advocate for further exploration of γ-linolenic acid in liver cancer treatments, indicating possible clinical applications.
Abstract
Our deep learning-guided workflow identified γ-linolenic acid as a natural FABP5 inhibitor and supports its potential as a lead compound for HCC therapy.